Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
- 1 December 2006
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 10 (6), 501-514
- https://doi.org/10.1016/j.ccr.2006.10.010
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Binding of p53 to the Central Domain of Mdm2 Is Regulated by PhosphorylationPublished by Elsevier BV ,2006
- A Second p53 Binding Site in the Central Domain of Mdm2 Is Essential for p53 UbiquitinationBiochemistry, 2006
- Mdmx as an essential regulator of p53 activityBiochemical and Biophysical Research Communications, 2005
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- Targeting the p53–MDM2 interaction to treat cancerBritish Journal of Cancer, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damageNature, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53Oncogene, 1999
- Regulation of p53 stability by Mdm2Nature, 1997